FDA Grants Emergency Approval for RSV Preventive Antibody for High-Risk Infants Amid Record Winter Surge
FDA approves nirsevimab, a monoclonal antibody RSV preventive for high-risk infants, as…
Search
Have an existing account?
Sign In
Tag: nirsevimab
